This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Universitéde Strasbourg. Active years: 2014-2015.
Company Filing History:
2 out of 5,383 
2 out of 186 
Years Active: 2014-2015
Title: Hermine Roudaut: Innovator in Hedgehog Protein Signaling Pathway
Introduction
Hermine Roudaut is a prominent inventor based in Marly-la-Ville, France. She has made significant contributions to the field of biomedical research, particularly in the modulation of the hedgehog protein signaling pathway. With a total of 2 patents, her work focuses on developing innovative compounds for therapeutic applications.
Latest Patents
Roudaut's latest patents include groundbreaking inventions related to compounds that modulate the hedgehog protein signaling pathway. One of her notable inventions involves compounds of formula (I) that are used as drugs for treating tumors associated with hyperactivation of the hedgehog protein signaling pathway. This invention also addresses neurodegenerative diseases, cerebral development disorders, and various cardiovascular conditions. Additionally, it encompasses methods for radio-marking these compounds and screening for ligands in the Smoothened receptor binding sites. Another patent focuses on acyl guanidine derivatives that also modulate the hedgehog protein signaling pathway, aimed at treating tissue dysfunctions linked to this pathway.
Career Highlights
Hermine Roudaut has worked with esteemed institutions such as the University of Strasbourg and the Centre National de La Recherche Scientifique. Her research has been pivotal in advancing our understanding of the hedgehog signaling pathway and its implications in various diseases.
Collaborations
Throughout her career, Roudaut has collaborated with notable colleagues, including Maurizio Taddei and Martial Ruat. These partnerships have enriched her research and contributed to the development of her innovative patents.
Conclusion
Hermine Roudaut's contributions to the field of biomedical research, particularly in the modulation of the hedgehog protein signaling pathway, highlight her role as a leading inventor. Her patents reflect her commitment to advancing medical science and improving treatment options for various diseases.